Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The request to the court comes a month after the agency settled with Express Scripts, under the condition the company change its wholesale buying practices, pass on manufacturer rebates and support TrumpRx.gov. Now it's up to CVS Caremark and UnitedHealth’s Optum Rx to make deals of their own.
The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time.
A fired employee of Nuance, a Microsoft subsidiary, is responsible for stealing records on 1.3 million patients from Geisinger Health in Pennsylvania. He has pleaded guilty as part of a deal with prosecutors.
Laborp said the platform from PathAI will allow it to move all laboratory workflow digital, including slide review. The onboard artificial intelligence aims to simplify diagnostics, improving accuracy and turnaround time.
The study by the nonprofit KFF is focused on the jump in overall healthcare prices from 2022 to 2024, with hospitals leading as a result of both delayed care from the pandemic and an increase in prices for services.
A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.
Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.
A total of 80 healthcare companies are among those that brought in the most revenue for the fiscal year, according to the magazine's most recent rankings.
Healthcare companies, including manufacturers that produce health products, announced a total of 33,085 layoffs in the first five months of 2023—an 81% increase compared to the same time frame in 2022.